IPA seeks CDSCO route to regularise legacy drugs lacking central approval records
The Indian Pharmaceutical Alliance has urged the CDSCO to regularise off-patent medicines that have been sold for 15–20 years but lack central approval records, including select anticonvulsant and mood-stabiliser formulations.
The Indian Pharmaceutical Alliance seeks CDSCO regularisation of legacy off-patent drugs marketed for years without central approval records, including several essential anticonvulsant and mood-stabiliser formulations.
Why this matters
No related recent signals are provided, so a broader recent Indian Pharmaceutical Alliance pattern cannot be established. The request focuses on regulatory certainty for long-marketed legacy medicines.
Retail-company signals are accelerating, up 204929% QoQ.